FERMENTA BIOTECH
Back to Balance Sheet
|
FERMENTA BIOTECH Last 5 Year Total Non-Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹29 Cr | ₹77 Cr | ₹97 Cr | ₹154 Cr | ₹131 Cr |
What is the latest Total Non-Current Liabilities ratio of FERMENTA BIOTECH ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2025 | ₹29 Cr |
| Mar2024 | ₹77 Cr |
| Mar2023 | ₹97 Cr |
| Mar2022 | ₹154 Cr |
| Mar2021 | ₹131 Cr |
How is Total Non-Current Liabilities of FERMENTA BIOTECH Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹29 Cr | -62.03 | |
| Mar2024 | ₹77 Cr | -20.94 | |
| Mar2023 | ₹97 Cr | -36.76 | |
| Mar2022 | ₹154 Cr | 17.22 | |
| Mar2021 | ₹131 Cr | - | |
Compare Total Non-Current Liabilities of peers of FERMENTA BIOTECH
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FERMENTA BIOTECH | ₹979.6 Cr | 1.6% | -5% | -12.4% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹400,497.0 Cr | -3.5% | -6.4% | -2.6% | Stock Analytics | |
| DIVIS LABORATORIES | ₹165,492.0 Cr | -5.8% | -1.6% | 10.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹136,013.0 Cr | 1.4% | 7% | 23.7% | Stock Analytics | |
| CIPLA | ₹112,922.0 Cr | -4.7% | -6.8% | -0.3% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,115.0 Cr | -2.8% | -8.1% | -11.1% | Stock Analytics | |
FERMENTA BIOTECH Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FERMENTA BIOTECH | 1.6% |
-5% |
-12.4% |
| SENSEX | -0.7% |
-1.9% |
8% |
You may also like the below Video Courses